MedTrace Logo

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

NCT06074068 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1080

Last updated 2026-04-15

No results posted yet for this study

Summary

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are:

1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment?
2. What are the trajectories of therapeutic change targets across interventions?
3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Conditions

  • Intimate Partner Violence
  • Child Maltreatment

Interventions

BEHAVIORAL

Fathers for Change

18 week individual therapy focused on fathers' emotion regulation, reflective functioning and family communication.

BEHAVIORAL

Duluth BIP

18 week individually delivered psychoeducation and CBT focused program focused on intimate partner violence

Sponsors & Collaborators

  • University of Connecticut

    collaborator OTHER

  • University of Delaware

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Carla S Stover, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-11
Primary Completion
2028-08-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06074068 on ClinicalTrials.gov